Skip to main content
. 2021 Jun 21;13(3):357–367. doi: 10.1007/s12560-021-09482-0

Table 1.

Demographic characteristics and clinical manifestations of norovirus-infected patients

Total GII.4 Othersa Untyped
GII.4 Sydney[P31] GII. 4 Sydney[P16]
Number of patients 168 (100.0%) 131 (78.0%) 20 (11.9%) 8 (4.8%) 9 (5.4%)
Sex(male) 103 (61.3%) 80 (61.1%) 12 (60.0%) 6 (75.0%) 5 (55.6%)
Age (month) 19.0 (13.0–28.8) 19.0 (13.0–28.0) 19.5 (14.3–38.5) 23.0 (21.3–36.8) 16.0 (11.5–29.0)
Number of hospitalisation 80 (47.6%) 63 (48.1%) 8 (40.0%) 3 (37.5%) 6 (66.7%)
Length of hospital stay(day) 5.0 (3.0–7.5) 5.0 (3.0–6.0) 4.5 (3.0–9.0) 8.0 (3.0–10.0) 9.5 (3.0–12.0)
Fever 56 (33.3%) 41 (31.3%) 9 (45.0%) 4 (50.0%) 2 (22.2%)
Body temperature (℃) 37 (37–37.9) 37 (37–37.8) 37 (37–38) 37.5 (37–39.73) 37 (36.6–37.4)
Vomiting 141 (83.9%) 111 (84.7%) 17 (85.0%) 7 (87.5%) 6 (66.7%)
Vomiting duration(day) 2.0 (1.0–3.0) 2.0 (1.0–3.0) 1.5 (1.0–3.0) 1 (1.0–1.8) 1 (0.0–3.5)
Max. no. vomiting episodes/24 h 3.0 (2.0–6.0) 3.0 (2.0–6.0) 4.0 (3.0–9.5) 4.0 (1.5–4.8) 3.0 (0.0–6.0)
Diarrhoea 132 (79.0%) 104 (80.0%) 15 (75.0%) 4 (50.0%) 9 (100.0%)
Diarrhoea duration (day) 2.0 (1.0–5.0) 2.0 (1.0–5.0) 2.0 (0.3–6.0) 0.5 (0.0–1.0)b 2.0 (1.0–3.0)
Max. no. diarrhoea stools/24 h 3.0 (1.0–6.0) 3.0 (1.0–5.0) 5.0 (0.3–8.8) 1.0 (0.0–2.8)c 4.0 (3.0–4.5)
Anorexia 82 (48.8%) 70 (53.4%) 8 (40.0%) 2 (25.0%) 2 (22.2%)
Dehydration 15 (8.9%) 13 (9.9%) 1 (5.0%) 1 (12.5%) 0 (0.0%)
Abdominal pain 22 (13.1%) 15 (11.5%) 4 (20.0%) 2 (25.0%) 1 (11.1%)
Bloating 11 (6.5%) 10 (7.6%) 1 (5.0%) 0 (0.0%) 0 (0.0%)
Nausea 21 (12.5%) 15 (11.5%) 3 (15.0%) 1 (12.5%) 2 (22.2%)
Seizures 38 (22.6%) 30 (22.9%) 5 (25.0%) 1 (12.5%) 2 (22.2%)
Modified Vesikari scale (MVS) 10.0 (8.0–13.0) 10.0 (8.0–13.0) 10.0 (8.0–14.5) 8.0 (6.3–10.0)d 9.0 (7.0–13.0)

aThe “Others” group contained three genotypes: GII.2[P16], GII.6[P7] and GII.13[P21]

bp = 0.004 < 0.05: GII.4 (2.0; IQR: 1.0–5.0) vs. Others

cp = 0.011 < 0.05: GII.4 (4.0; IQR: 1.0–6.0) vs. Others

dp = 0.044 < 0.05: GII.4 (10.0; IQR: 8.0–13.0) vs. Others